The Esaote Group, founded in the 1980's, is a global leader in research, production, and marketing of medical diagnostic equipment and related services. Esaote offers integrated diagnostic solutions for ultrasound electromedical diagnostic systems, and MRI. The Esaote MR equipment is dedicated for specific clinical applications, as distinguished from conventional whole body MRI systems. This MRI product family is based on a unique, proprietary technology developed specifically for musculoskeletal imaging.
The Italian based company is a member of the Bracco Group.
Esaote North America is the exclusive U.S. distributor of MRI devices manufactured by Esaote.

MRI Scanners:

0.2T to 0.31T:
Vet-MR (Based on the E Scan XQ, dedicated to the veterinarian practice.)

[This entry is marked for removal.]

Hitachi Medical Systems America, Inc. (HMSA), was a major provider of magnetic resonance imaging systems in the United States. Hitachi had more than 2300 installed permanent magnet MR imaging systems worldwide. As a full-line supplier of medical imaging equipment in Japan, Hitachi Medical Corporation (HMC) founded HMSA to provide a direct link to the U.S. marketplace. Altaire™ , the open MR system from Hitachi, extends the family of open MRI products.

In December 2019 Japan's Fujifilm announced the acquisition of Hitachi's diagnostic imaging business for 179 billion yen ($1.63 billion). This includes Hitachi’s CT, MRI, X-ray, and ultrasound imaging operations, also its electronic health record business. Fujifilm expects the deal to close in July 2020 subject to regulatory clearances.

MRI Scanners:

0.3T to 0.7T:
1.5T:

Lantheus Medical Imaging is a worldwide leader in medical imaging, with headquarters in North Billerica, Massachusetts, and nearly 700 employees worldwide with offices in Puerto Rico, Canada, and Australia.
The product portfolio includes ABLAVAR™ (gadofosveset trisodium) a blood pool contrast agent for magnetic resonance angiography MRA, Cardiolite® (Kit for the preparation of Technetium Tc99m Sestamibi), a cardiac perfusion imaging agent and DEFINITY® Vial for (Perflutren Lipid Microsphere) injectable suspension, the leading cardiac ultrasound contrast agent in the US.

MRI Contrast Agents:

Possible MR guided interventions are breast MRI, liver and bone biopsies. Open MRI is advantageous to guide interventional procedures because this type of MRI scanner provides a better patient access.
Before the MRI guided biopsy is started, all the necessary precautions ensuring normal sterile and safe conditions for an intervention have to be performed. This includes the special safety issues concerning MRI surroundings and special equipment, like non-magnetic biopsy needles, localization tools (e.g. wires to mark lesions prior to surgery with breast MRI guidance) etc.

See also 5 Gauss Line, Contraindications, Low Field MRI, MR Compatibility, Magnetic Resonance Guided Focused Ultrasound and Computer Aided Detection.

Mallinckrodt, a Tyco Healthcare company makes and distributes products for respiratory care; bulk and dosage pharmaceuticals, primarily for pain relief and addiction therapy; and imaging agents for magnetic resonance, ultrasound, X-ray, and nuclear medicine applications. With worldwide manufacturing and distribution facilities, as well as worldwide sales offices, Mallinckrodt sells its products worldwide.
GastroMARK® is marketed in the United States by Mallinckrodt, Inc.

In June 2007 Tyco International Ltd. completed the separation of its healthcare business, which is named Covidien. Mallinckrodt, Inc. is now part of Covidien Ltd.

MRI Contrast Agents: